These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22451668)

  • 1. Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2.
    Ortiz D; Voyvodic P; Gossack L; Quast U; Bryan J
    J Biol Chem; 2012 May; 287(22):17985-95. PubMed ID: 22451668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
    Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
    J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
    de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinterpreting the action of ATP analogs on K(ATP) channels.
    Ortiz D; Gossack L; Quast U; Bryan J
    J Biol Chem; 2013 Jun; 288(26):18894-902. PubMed ID: 23665564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes.
    de Wet H; Proks P; Lafond M; Aittoniemi J; Sansom MS; Flanagan SE; Pearson ER; Hattersley AT; Ashcroft FM
    EMBO Rep; 2008 Jul; 9(7):648-54. PubMed ID: 18497752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
    Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
    Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
    Proks P; de Wet H; Ashcroft FM
    J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
    Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
    Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy.
    Matsuo M; Trapp S; Tanizawa Y; Kioka N; Amachi T; Oka Y; Ashcroft FM; Ueda K
    J Biol Chem; 2000 Dec; 275(52):41184-91. PubMed ID: 10993895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
    Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
    EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1.
    Ueda K; Inagaki N; Seino S
    J Biol Chem; 1997 Sep; 272(37):22983-6. PubMed ID: 9287292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
    Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
    Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
    Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
    J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.